These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22205102)

  • 1. Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
    Lewis J; Walker AS; Castro H; De Rossi A; Gibb DM; Giaquinto C; Klein N; Callard R
    J Infect Dis; 2012 Feb; 205(4):548-56. PubMed ID: 22205102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
    Picat MQ; Lewis J; Musiime V; Prendergast A; Nathoo K; Kekitiinwa A; Nahirya Ntege P; Gibb DM; Thiebaut R; Walker AS; Klein N; Callard R;
    PLoS Med; 2013 Oct; 10(10):e1001542. PubMed ID: 24204216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART.
    Ujeneza EL; Ndifon W; Sawry S; Fatti G; Riou J; Davies MA; Nieuwoudt M;
    Elife; 2021 Jan; 10():. PubMed ID: 33443013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status.
    van Rossum AM; Scherpbier HJ; van Lochem EG; Pakker NG; Slieker WA; Wolthers KC; Roos MT; Kuijpers JH; Hooijkaas H; Hartwig NG; Geelen SP; Wolfs TF; Lange JM; Miedema F; de Groot R;
    AIDS; 2001 Nov; 15(17):2267-75. PubMed ID: 11698700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
    Newell ML; Patel D; Goetghebuer T; Thorne C;
    J Infect Dis; 2006 Apr; 193(7):954-62. PubMed ID: 16518757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
    Yin DE; Warshaw MG; Miller WC; Castro H; Fiscus SA; Harper LM; Harrison LJ; Klein NJ; Lewis J; Melvin AJ; Tudor-Williams G; McKinney RE;
    Pediatrics; 2014 Oct; 134(4):e1104-16. PubMed ID: 25266426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents - The-ANRS-EP59-CLEAC Study.
    Frange P; Montange T; Le Chenadec J; Batalie D; Fert I; Dollfus C; Faye A; Blanche S; Chacé A; Fourcade C; Hau I; Levine M; Mahlaoui N; Marcou V; Tabone MD; Veber F; Hoctin A; Wack T; Avettand-Fenoël V; Warszawski J; Buseyne F
    Front Immunol; 2021; 12():662894. PubMed ID: 33968064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database.
    Means AR; Risher KA; Ujeneza EL; Maposa I; Nondi J; Bellan SE
    PLoS One; 2016; 11(10):e0164148. PubMed ID: 27716818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.
    Vrisekoop N; van Gent R; de Boer AB; Otto SA; Borleffs JC; Steingrover R; Prins JM; Kuijpers TW; Wolfs TF; Geelen SP; Vulto I; Lansdorp P; Tesselaar K; Borghans JA; Miedema F
    J Immunol; 2008 Jul; 181(2):1573-81. PubMed ID: 18606713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.
    Koethe JR; Jenkins CA; Shepherd BE; Stinnette SE; Sterling TR
    Clin Infect Dis; 2011 Nov; 53(9):952-60. PubMed ID: 21946189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord
    HIV Med; 2019 Aug; 20(7):456-472. PubMed ID: 31099155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
    Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
    AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection.
    Mori M; Adland E; Paioni P; Swordy A; Mori L; Laker L; Muenchhoff M; Matthews PC; Tudor-Williams G; Lavandier N; van Zyl A; Hurst J; Walker BD; Ndung'u T; Prendergast A; Goulder P; Jooste P
    PLoS One; 2015; 10(7):e0131591. PubMed ID: 26151555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents.
    Alvarez P; Mwamzuka M; Marshed F; Kravietz A; Ilmet T; Ahmed A; Borkowsky W; Khaitan A
    PLoS One; 2017; 12(12):e0190332. PubMed ID: 29287090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
    Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
    Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to combination antiretroviral therapy: variation by age.
    ; Sabin CA; Smith CJ; d'Arminio Monforte A; Battegay M; Gabiano C; Galli L; Geelen S; Gibb D; Guiguet M; Judd A; Leport C; Dabis F; Pantazis N; Porter K; Raffi F; Thorne C; Torti C; Walker S; Warszawski J; Wintergerst U; Chene G; Lundgren J
    AIDS; 2008 Jul; 22(12):1463-73. PubMed ID: 18614870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.